SHEL.UK

2,526

+1.28%↑

BP

383.7

+0.91%↑

SHEL.UK

2,526

+1.28%↑

BP

383.7

+0.91%↑

SHEL.UK

2,526

+1.28%↑

BP

383.7

+0.91%↑

SHEL.UK

2,526

+1.28%↑

BP

383.7

+0.91%↑

SHEL.UK

2,526

+1.28%↑

BP

383.7

+0.91%↑

Search

Smith & Nephew PLC

Open

1,064 -1.34

Overview

Share price change

24h

Current

Min

1063

Max

1084.5

Key metrics

By Trading Economics

Income

107M

Sales

1.4B

P/E

Sector Avg

30.871

23.767

EPS

0.376

Dividend yield

2.68

Profit margin

7.57

Employees

17,349

EBITDA

260M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+15.17% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.68%

5.86%

Next Earnings

5 Aug 2025

Market Stats

By TradingEconomics

Market Cap

432M

9.5B

Previous open

1065.34

Previous close

1064

Smith & Nephew PLC Chart

Past performance is not a reliable indicator of future results.

Related News

12 May 2025, 22:34 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 May 2025, 23:48 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12 May 2025, 23:46 UTC

Market Talk

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12 May 2025, 23:34 UTC

Market Talk

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12 May 2025, 23:21 UTC

Market Talk

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12 May 2025, 22:54 UTC

Market Talk

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12 May 2025, 22:43 UTC

Earnings

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12 May 2025, 22:14 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 May 2025, 22:08 UTC

Acquisitions, Mergers, Takeovers

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12 May 2025, 22:08 UTC

Acquisitions, Mergers, Takeovers

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12 May 2025, 22:07 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12 May 2025, 22:07 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Australia Retail Electricity Business to AGL

12 May 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12 May 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12 May 2025, 22:05 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12 May 2025, 22:04 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 May 2025, 21:15 UTC

Top News

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12 May 2025, 21:01 UTC

Earnings

Constellation Software 1Q Rev $2.65B >CSU.T

12 May 2025, 21:01 UTC

Earnings

Constellation Software 1Q Net $115M >CSU.T

12 May 2025, 21:01 UTC

Earnings

Constellation Software 1Q EPS $5.44 >CSU.T

12 May 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 May 2025, 20:50 UTC

Market Talk
Earnings

Basic Materials Roundup: Market Talk

12 May 2025, 20:44 UTC

Top News

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12 May 2025, 20:31 UTC

Top News

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12 May 2025, 20:24 UTC

Earnings

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12 May 2025, 20:24 UTC

Earnings

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12 May 2025, 20:24 UTC

Top News

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12 May 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12 May 2025, 20:15 UTC

Earnings

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12 May 2025, 20:10 UTC

Earnings

Blink Charging 1Q Rev $20.8M >BLNK

Peer Comparison

Price change

Smith & Nephew PLC Forecast

Price Target

By TipRanks

15.17% upside

12 Months Forecast

Average 1,231.2 GBX  15.17%

High 1,400 GBX

Low 1,025 GBX

Based on 10 Wall Street analysts offering 12 month price targets forSmith & Nephew PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

4

Buy

6

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

$

About Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.